partnering

News

Novo Nordisk’s Flagship alliance bears obesity, MASH fruit

Novo Nordisk has reaped the first harvest from its wide-ranging alliance with life sciences investor Flagship Pioneering, buying rights to two programmes from the VC’s por

News

Boehringer targets NASH/MASH with $2bn Ribo alliance

Boehringer Ingelheim has signed a multi-target collaboration with China’s Suzhou Ribo Life Science and its Swedish unit Ribocure to develop treatments for non-alcoholic or

News

Novartis opens new frontier in Voyager gene therapy alliance

Novartis has doubled down on its gene therapy collaboration with Voyager Therapeutics, stumping up another $1.2 billion-plus in potential milestone payments and directing

News

Astellas strikes $1.7bn SIRP drug deal with Elpiscience

Astellas has struck a deal with fellow Japanese pharma company Elpiscience to develop up to four cancer immunotherapies that work by revving up the activity of macrophages

News

AI specialist Fauna grabs $494m Lilly obesity alliance

A US biotech that is trying to find new avenues for treating human diseases by studying the genomics of animal species, Fauna Bio, has agreed a deal with Eli Lilly focusin

News

GSK taps Hansoh for another cancer ADC candidate

GSK has turned to China’s Hansoh Pharma to add another antibody-drug conjugate (ADC) to its oncology pipeline, this time licensing a B7-H3-targeting candidate for $185 million upfront

Novo Nordisk’s Flagship alliance bears obesity, MASH fruit

Boehringer targets NASH/MASH with $2bn Ribo alliance

Novartis opens new frontier in Voyager gene therapy alliance

Astellas strikes $1.7bn SIRP drug deal with Elpiscience

AI specialist Fauna grabs $494m Lilly obesity alliance

GSK taps Hansoh for another cancer ADC candidate

Repligen builds in cell therapy with $1.5bn BioLife takeover

Discover a new era of healthcare panel engagement: Grounded ...

partnering

Editor's Picks